Dr. Deniz Gülfem Öztürk received her bachelor’s degree from Bilkent University, Department of Molecular Biology and Genetics, in 2011. Following her graduation, she joined Prof. Utkan Demirci’s lab at Harvard Medical School Brigham and Women's Hospital and Harvard-MIT Institute of Health Sciences and Technologies as a visiting researcher. She holds a PhD degree from Sabanci University, Molecular Biology, Genetics and Bioengineering Department, under the supervision of Prof. Devrim Gozuacik. During her doctoral studies, she focused on transcriptional and epigenetic regulation of stress responses in cancer. Dr. Öztürk continues her postdoctoral studies on identifying novel therapeutic targets in breast cancer through organoid models and genome-scale CRISPR-Cas9 screens.
Dr. Deniz Gülfem Öztürk received her bachelor’s degree from Bilkent University, Department of Molecular Biology and Genetics, in 2011. Following her graduation, she joined Prof. Utkan Demirci’s lab at Harvard Medical School Brigham and Women's Hospital and Harvard-MIT Institute of Health Sciences and Technologies as a visiting researcher. She holds a PhD degree from Sabanci University, Molecular Biology, Genetics and Bioengineering Department, under the supervision of Prof. Devrim Gozuacik. During her doctoral studies, she focused on transcriptional and epigenetic regulation of stress responses in cancer. Dr. Öztürk continues her postdoctoral studies on identifying novel therapeutic targets in breast cancer through organoid models and genome-scale CRISPR-Cas9 screens.